long term semaglutide use GLP-1 Vs Zepbound For Weight Loss Semaglutide vs. Tirzepatide: Which Is
Description
In the absence of signs and symptoms, elevations in pancreatic enzymes alone are not predictive of acute pancreatitis
Beyond weight reduction, semaglutide fosters improvements in key cardiovascular health markersdelivering not a simple weight loss remedy, but a comprehensive avenue to enduring health benefits
The SELECT trial (2023) in non-diabetic patients with obesity and established CVD reported a 20% MACE reduction (HR 0.80, 95% CI 0.720.90), driven by reductions in MI and stroke, marking a paradigm shift for GLP-1 agonists in primary prevention [12]
Wegovy is approved specifically for obesity management, yet Ozempic, approved for diabetes management, appears to be more popular (Han et al
